Country for PR: United Kingdom
Contributor: PR Newswire Europe
Tuesday, August 31 2021 - 21:00
AsiaNet
Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA-Seq of Tissue, Cells and Blood Samples
LAUSANNE, Switzerland, Aug. 31, 2021 /PRNewswire-AsiaNet/--

Alithea Genomics, a rapidly growing player in the transcriptomics field, has 
announced today the launch of its first MERCURIUS BRB-seq kits, which enable 
high-throughput and cost-efficient RNA-seq library preparation from a wide 
range of RNA samples.

BRB-seq is Alithea's flagship technology and is based on early sample barcoding 
and pooling. With BRB-seq, right after the initial reverse transcription 
reaction, hundreds of RNA samples can be processed in one single tube. This 
translates into a significant reduction of reagents and manual effort involved 
in the overall workflow.

The MERCURIUS BRB-seq kits provide an optimized set of barcodes, which ensure 
uniform and reproducible data generation from a large number of samples. 

Moreover, the newly launched BRB-seq kits are also optimized for RNA samples 
from various tissue types. In addition to standard purified RNA, the BRB-seq 
kits are also compatible with cell lysates (i.e. no need for RNA extraction) 
and for blood RNA samples (i.e. globin depletion is integrated in the BRB-seq 
workflow).

"We are particularly proud of our first kits, especially after a successful 
beta-testing period with early adopters" said Daniel Alpern, CTO at Alithea 
Genomics. "BRB-seq has already proved itself an empowering solution for several 
users and now, through our kits, we want to make easy and convenient for anyone 
to adopt this new technology".

More information can be requested at info@alitheagenomics.com or visiting: 
https://www.alitheagenomics.com/contact

About Alithea Genomics

Founded in 2020, Alithea Genomics SA is a rapidly growing provider of 
high-throughput RNA-seq services, kits and bioinformatic solutions. Alithea's 
products are ideal for large-scale transcriptomics studies such as biomarker 
discovery, antibody development and drug screening. In addition to human 
health, BRB-seq can easily be applied to model organisms, plants and in-vitro 
models.

Alithea Genomics is a privately held company based in Lausanne (Switzerland) 
and is currently shipping its kits directly and worldwide. For more information 
about Alithea Genomics, visit: https://www.alitheagenomics.com/

Contact: Riccardo Dainese
         CEO
         riccardo.dainese@alitheagenomics.com
         +41-788-30-31-39

Logo - https://mma.prnewswire.com/media/1603362/Alithea_Genomics_Logo.jpg 

SOURCE:  Alithea Genomics
Translations

Japanese